Inspector General Questions FDA’s Accelerated Approval for Biogen, Sarepta Drugs - BioSpace

[anonymous]

Inspector General Questions FDA’s Accelerated Approval for Biogen, Sarepta Drugs - BioSpace

An OIG report zeroed in on what it said were three particularly problematic accelerated approvals: Biogen’s Aduhelm, Sarepta’s Exondys and Covis’ Makena.​

https://www.biospace.com/fda/inspec...accelerated-approval-for-biogen-sarepta-drugs

 

[anonymous]

Never. Getting. Approved.